This compound is a protected nucleoside derivative used as an intermediate in the synthesis of modified nucleosides for pharmaceutical research. It features a thymine base with a silyl-protected hydroxyl and a dimethoxytrityl-protected primary alcohol, enabling selective chemical modifications.
Geltungsbereich: Die Informationen auf dieser Seite betreffen die Identifizierung von Chemikalien sowie industrielle Liefer-, Forschungs- und Produktionskontexte. Sie stellen keine Heilversprechen, medizinische Beratung oder Anwendungshinweise für Arzneimittel dar.
Beschaffen oder liefern Sie diese Verbindung?
Inventar einstellen oder Kaufanfrage stellen
CAS 875302-43-5
5'-O-(4,4'-Dimethoxitrityl)-2'-O-(tert-butyldimethylsilyl)-1-N-methylpseudouridine
Pharmaceutical intermediate for modified nucleosides
5'-O-(4,4'-dimethoxitrityl)-1-N-methylpseudouridine
Pharmaceutical intermediate for RNA synthesis
5'-DMT-3'-O-TBDMS-PseudoUridine
pharmaceutical intermediate for modified nucleosides
5'-DMT-3'-O-TBDMS-N1-Me-Pseudouridine-CE-Phosphoramidite
Phosphoramidite building block for RNA synthesis
[3-[4-(4-aminobenzoyl)oxyphenyl]-2-(octadec-9-enoylamino)propyl] phosphate;[3-(4-iodophenyl)-2-(octadec-9-enoylamino)propyl] phosphate;[3-[4-[(3-methoxyphenyl)methoxy]phenyl]-2-(octadec-9-enoylamino)propyl] phosphate;bis([2-(octadec-9-enoylamino)-3-[4-[(4-pentylphenyl)methoxy]phenyl]propyl] phosphate);[2-(octadec-9-enoylamino)-3-(4-phenylphenyl)propyl] phosphate;[2-(octadec-9-enoylamino)-3-(4-prop-2-enoxyphenyl)propyl] phosphate
raw material for therapeutic antibody
(4S,5R)-5-(3,5-bis(trifluoromethyl)phenyl)-4-methyloxazolidin-2-one
Pharmaceutical intermediate for fine chemicals
(4-Fluoro-5-isopropyl-2-methoxyphenyl)boronic acid
Pharmaceutical intermediate
5'-O-DMT-2'-O-TBDMS-Pseudouridine
Pharmaceutical intermediate for nucleoside synthesis
5-[(2S,3S,4S,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[tert-butyl(dimethyl)silyl]oxy-3-hydroxyoxolan-2-yl]-1-methylpyrimidine-2,4-dione
DOMAILDWCRIGEQ-JDIHBLRXSA-N
CC(C)(C)[Si](C)(C)O[C@@H]1[C@H](O[C@H]([C@@H]1O)C2=CN(C(=O)NC2=O)C)COC(C3=CC=CC=C3)(C4=CC=C(C=C4)OC)C5=CC=C(C=C5)OC
—